Clinical Trials

1,500 enrolled

Phase 1/2 Active not recruiting

Solid Tumor, Adult

NCT01064648 2026-03-18

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

117 enrolled 23 charts

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT01434316 2026-03-18

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

121 enrolled

Advanced Malignant Solid Neoplasm

NCT02453620 2026-03-18

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

BreastOther solid neoplasm

57 enrolled

Anatomic Stage III Breast Cancer AJCC v8

NCT02535312 2026-03-18

Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

Phase 1/2 Active not recruiting

30 enrolled 15 charts

Mesothelioma, Malignant

NCT04158336 2026-03-18

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

Phase 1 Completed

274 enrolled

Solid Tumor

NCT04491942 2026-03-18

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

BreastGenitourinaryGynecologicOther solid neoplasmThoracic

74 enrolled

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

NCT05101070 2026-03-18

aCCeleR8-001

282 enrolled

Solid Tumors

NCT05203172 2026-03-18

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Phase 4 Recruiting

46 enrolled

Solid Tumors

NCT05223608 2026-03-18

ImmuCCo

Phase NA Recruiting

500 enrolled

Solid Tumor, Adult

NCT05689853 2026-03-18

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

87 enrolled

Solid Tumor, Adult

NCT06009926 2026-03-18

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

Other neoplasmOther solid neoplasm

72 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT06126276 2026-03-18

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Phase 2 Recruiting

70 enrolled

Malignant Female Reproductive System Neoplasm

NCT06136897 2026-03-18

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

35 enrolled 10 charts

Malignant Solid Neoplasm

NCT06233942 2026-03-18

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

308 enrolled

Advanced Solid Tumor

NCT06248411 2026-03-18

A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors

189 enrolled

Advanced or Metastatic Solid Tumors

NCT06351371 2026-03-18

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

35 enrolled 10 charts

Malignant Solid Neoplasm

NCT06487858 2026-03-18

A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

75 enrolled

Solid Tumor

NCT06585488 2026-03-18

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

GastrointestinalOther solid neoplasmThoracic

514 enrolled

Metastatic Solid Tumors

NCT06725173 2026-03-18

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

100 enrolled

Phase 1 Not yet recruiting

Recurrence, Retinoblastoma

NCT07480681 2026-03-18

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

138 enrolled

Phase 2 Not yet recruiting

Advanced/Metastatic Solid Tumors

NCT07480733 2026-03-18

A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors

480 enrolled

Advanced Malignant Solid Tumors

NCT05023655 2026-03-17

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

Phase 2 Terminated

20 enrolled

Solid Tumor

NCT05155332 2026-03-17

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

190 enrolled

Solid Tumors

NCT06056024 2026-03-17

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Phase 1 Completed

47 enrolled

Solid Tumor, KRAS Mutation

NCT06360588 2026-03-17

Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)

22 enrolled 9 charts

Malignant Solid Neoplasm

NCT06581432 2026-03-17

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Phase 2 Recruiting

430 enrolled

Solid Tumours

NCT06654050 2026-03-17

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Phase 2 Withdrawn

Mesothelioma, Malignant, Mesothelioma

NCT06927297 2026-03-17

Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

12 enrolled

Advanced Solid Tumor Malignancies

NCT06960395 2026-03-17

Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

450 enrolled

Solid Tumor Malignancies

NCT07477743 2026-03-17

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

331 enrolled

Advanced Solid Tumor Cancer

NCT07477886 2026-03-17

Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer

Not yet recruiting

134 enrolled

Phase 1/2 Active not recruiting

Hematopoietic and Lymphatic System Neoplasm

NCT03600883 2026-03-16

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

713 enrolled 1 FDA

KRAS p.G12C Mutant Advanced Solid Tumors

NCT06840834 2026-03-16

Bi-MAPS

Phase 2 Recruiting

38 enrolled

Phase 1 Not yet recruiting

Mesothelioma, Malignant

NCT07475559 2026-03-16

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

42 enrolled

Advanced Solid Tumor Malignancies

NCT01950572 2026-03-13

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

GastrointestinalGynecologicOther solid neoplasmThoracic

1,000 enrolled

Biliary Tract Neoplasms, Lung Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thymoma

NCT05571839 2026-03-13

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

DermatologicGastrointestinalOther solid neoplasmThoracic

41 enrolled

Carcinoma, Non-Small-Cell Lung, Melanoma, Mesothelioma, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05957536 2026-03-13

A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors

128 enrolled

HER-2 Positive Advanced Solid Tumors

NCT06307795 2026-03-13

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

63 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Phase 1 Terminated

37 enrolled

Solid Tumor, Adult

NCT06565260 2026-03-13

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

Phase NA Recruiting

150 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT06736704 2026-03-13

SNV4818 in Participants With Advanced Solid Tumors

320 enrolled

Phase NA Not yet recruiting

Advanced Solid Tumors

NCT06771739 2026-03-13

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

20 enrolled

Malignant Solid Neoplasm

NCT06892379 2026-03-13

A Study of HS-20110 in Participants With Advanced Solid Tumors

475 enrolled

Solid Tumors

NCT07207707 2026-03-13

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

78 enrolled

Solid Tumor Malignancies

NCT07223125 2026-03-13

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

360 enrolled

Advanced-stage Solid Tumors

NCT07300943 2026-03-13

Study in Advanced Solid Tumor Patients

306 enrolled

Advanced Solid Tumor

NCT07456436 2026-03-13

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

50 enrolled

Phase 1/2 Not yet recruiting

Hematopoietic and Lymphatic System Neoplasm

NCT07469774 2026-03-13

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

111 enrolled

Phase 1 Not yet recruiting

Locally Advanced or Metastatic Solid Tumors

NCT07469982 2026-03-13

A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors

122 enrolled